Related Experiment Video
Updated: May 25, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Breastfeeding and lung function at school age: does maternal asthma modify the effect?
Cristian M Dogaru1, Marie-Pierre F Strippoli, Ben D Spycher
1Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Insights
Breastfeeding for over four months, particularly in children of mothers with asthma, is linked to improved school-age lung function. This suggests a direct impact on lung development rather than protection against infections or allergies.
Area of Science:
- Pediatric Pulmonology
- Epidemiology
- Maternal and Child Health
Background:
- Conflicting evidence exists regarding breastfeeding's impact on lung function.
- The potential modifying role of maternal asthma in this association is unclear.
Purpose of the Study:
- To investigate the relationship between the duration of breastfeeding and lung function in school-aged children.
- To determine if maternal asthma influences the association between breastfeeding and lung function.
Main Methods:
- The Leicestershire Cohort Studies assessed breastfeeding duration, other exposures, and respiratory symptoms.
- Lung function parameters including forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and forced mid-expiratory flow (FEF50) were measured at age 12.
- Multivariable linear regression analysis was used with 1,458 participants.
Main Results:
- Longer breastfeeding duration (>4 months) was associated with higher forced mid-expiratory flow (FEF50) in all children.
- In children of mothers with asthma, breastfeeding was also associated with increased forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1).
- These associations remained significant after adjusting for infant infections and childhood asthma/atopy.
Conclusions:
- Breastfeeding for over four months is linked to enhanced lung function (FEF50) in school-aged children.
- The positive effects on FVC and FEV1 were particularly evident in children whose mothers had asthma.
- The findings suggest a direct effect of breastfeeding on lung growth, independent of early-life infections or atopy.
Rationale:
The evidence for an effect of breastfeeding on lung function is conflicting, in particular whether the effect is modified by maternal asthma.
Objectives:
To explore the association between breastfeeding and school-age lung function.
Methods:
In the Leicestershire Cohort Studies we assessed duration of breastfeeding (not breastfed, ≤3 months, 4-6 months, and >6 months), other exposures, and respiratory symptoms by repeated questionnaires. Post-bronchodilator FVC, FEV(1), peak expiratory flow (PEF), forced midexpiratory flow (FEF(50)), and skin prick tests were measured at age 12 years. We performed multivariable linear regression and tested potential causal pathways (N = 1,458).
Measurements And Main Results:
In the entire sample, FEF(50) was higher by 130 and 164 ml in children breastfed for 4 to 6 months and longer than 6 months, respectively, compared with those not breastfed (P = 0.048 and 0.041), with larger effects if the mother had asthma. FVC and FEV(1) were associated with breastfeeding only in children of mothers with asthma (P for interaction, 0.018 and 0.008): FVC was increased by 123 and 164 ml for those breastfed 4 to 6 months or longer than 6 months, respectively (P = 0.177 and 0.040) and FEV(1) was increased by 148 and 167 ml, respectively (P = 0.050 and 0.016). Results were unchanged after adjustment for respiratory infections in infancy and asthma and atopy in the child.
Conclusions:
In this cohort, breastfeeding for more than 4 months was associated with increased FEF(50) and, in children of mothers with asthma, with increased FEV(1) and FVC. It seems that the effect is not mediated via avoidance of early infections or atopy but rather through a direct effect on lung growth.
Related Concept Videos
Asthma-I: Introduction
Asthma I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: